Alejandro EU, Gregg B, Blandino-Rosano M, Cras-Méneur C, Bernal-Mizrachi E. Natural history of -cell adaptation and failure in type 2 diabetes. Mol Aspects Med. 2015;42:19-41. https://pubmed.ncbi.nlm.nih.gov/25542976 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404183 https://doi.org/10.1016/j.mam.2014.12.002

Kraft JR. Detection of diabetes mellitus in situ (occult diabetes). Lab Med. 1975;6(2):10-22. https://doi.org/10.1093/labmed/6.2.10

DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37(6):667-87. https://pubmed.ncbi.nlm.nih.gov/3289989 https://doi.org/10.2337/diab.37.6.667

Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2005;90(1):493-500. https://pubmed.ncbi.nlm.nih.gov/15483086. https://doi.org/10.1210/jc.2004-1133

Hupfeld CJ, Courtney CH Olefsky JM. Type 2 diabetes mellitus: etiology, pathogenesis and natural history. In: Jameson JL, De Groot LJ, eds. Endocrinology adult and paediatric, vol. 1, 6th ed. Philadelphia: Saunders Elsevier. 2010.

Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C. Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res. 2005;97(7):725-33. https://pubmed.ncbi.nlm.nih.gov/16123336 https://doi.org/10.1161/01.RES.0000183730.52908.C6

Walcher D, Marx N. C-peptide in the vessel wall. Rev Diabet Stud. 2009;6(3):180-6. https://pubmed.ncbi.nlm.nih.gov/20039007 https://doi.org/10.1900/RDS.2009.6.180

Vasic, Walcher D. C-peptide: a new mediator of atherosclerosis in diabetes. Mediators Inflamm. 2012;2012:858692. https://pubmed.ncbi.nlm.nih.gov/22547909 https://doi.org/10.1155/2012/858692

Chen Z, He J, Ma Q, Xiao M. Association between c-peptide level and subclinical myocardial injury. Front Endocrinol (Lausanne). 2021;12:680501. https://pubmed.ncbi.nlm.nih.gov/34456859 https://doi.org/10.3389/fendo.2021/680501

Baltali M, Korkmaz ME, Kiziltan HT, Muderris IH, Ozin B, Anarat R. Association between postprandial hyperinsulinemia and coronary artery disease among non-diabetic women: a case control study. Int J Cardiol. 2003;88(2-3):215-21. https://pubmed.ncbi.nlm.nih.gov/12714201 https://doi.org/10.1016/s0167-5273(02)00399-6

Brohall G, Oden A, Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes and impaired tolerance: a systematic review. Diabet Med. 2006;23(6):609-16. https://pubmed.ncbi.nlm.nih.gov/16759301 https://doi.org/10.1111/j.1464-5491.2005.01725.x

Su Y, Liu XM, Sun YM, Wang YY, Luan Y, Wu Y. Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance and type 2 diabetes mellitus. Am J Cardiol. 2008;102(4):497-8. https://pubmed.ncbi.nlm.nih.gov/18678313 https://doi.org/10.1016/j.amjcard.2008.03.087

Li CH, Wu JS, Yang YC, Shih CC, Lu FH, Chang CJ. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose. J Clin Endocrinol Metab. 2012;97(4):E658-662. https://pubmed.ncbi.nlm.nih.gov/22337914 https://doi.org/10.1210/jc.2011-2595

Yamaji T, Harada T, Hashimoto Y, et al. Pre-impaired fasting glucose state is a risk factor for endothelial dysfunction: Flow-mediated dilation Japan (FMD-J) study. BMJ Open Diabetes Res Care. 2020;8(1):e001610. https://pubmed.ncbi.nlm.nih.gov/33028539 https://doi.org/10.1136/bmjdrcc-2020-001610

Matawaran B, Mercado-Asis LB. Comparison of pancreatic insulin response to hyperglycemia among Filipino subjects of various glycemic status. Philipp J Intern Med. 2009;47(1):25-30.

Valdez VAU, Mercado-Asis LB, Lopez AA, et al. Determination of nonalcoholic fatty liver disease in patients with pre-impaired glucose tolerance. Philipp J Intern Med. 2017;55(2):1-6.

Torres-Salvador PD, Malaza G, Mercado-Asis LB. Correlation of glycosylated hemoglobin and oral glucose tolerance test results in hyperinsulinemic pre-impaired glucose tolerance state versus normoinsulinemic-normal OGTT. J Med UST. 2018;2(1):155-9. https://doi.org/10.35460/2546-1621.2017-0042

Cefalu WT, Buse JB, Tuomilehto J, et al. Update and next steps for real-world translation of interventions for type 2 diabetes prevention: reflections from Diabetes Care Editors’ Expert Forum. Diabetes Care. 2016;39(7):1186-1201. https://pubmed.ncbi.nlm.nih.gov/27631469 https://doi.org/10.2337/dc16-0873

World Health Organization (WHO). International Association for the Study of Obesity (IASO) and International Obesity Task Force (IOTF). The Asia-Pacific perspective: redefining obesity and its treatment. 2000. https://iris.who.int/bitstream/handle/10665/206936/0957708211_eng.pdf. Accessed on March 4, 2022.

Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence. A scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38(9):1777-1803. https://pubmed.ncbi.nlm.nih.gov/26246459 https://doi.org/10.2337/dci15-0012

Viechtbauer W, Smits L, Kotz D, et al. A simple formula for the calculation of sample size in pilot studies. J Clin Epidemiol. 2015;68(11): 1375-9. https://pubmed.ncbi.nlm.nih.gov/26146089 https://doi.org/10.1016/j.jclinepi.2015.04.014

Skaug EA, Madssen E, Aspenes ST, Wisløff U, Ellingsen Ø. Cardiovascular risk factors have larger impact on endothelial function in self-reported health women than men in the HUNT3 Fitness study. PLoS One. 2014;.9(7):e101371. https://pubmed.ncbi.nlm.nih.gov/24991924 https://doi.org/10.1371/journal.pone.0101371

Crofts C, Schofield G, Zinn C, Wheldon M, Kraft J. Identifying hyperinsulinemia in the absence of impaired glucose tolerance: An examination of the Kraft database. Diabetes Res Clin Pract. 2016;118:50-57. https://pubmed.ncbi.nlm.nih.gov/27344544 https://doi.org/10.1016/j.diabres.2016.06.007

Crofts CAP, Schofield G, Wheldon MC, Zinn C, Kraft JR. Determining a diagnostic algorithm for hyperinsulinemia. J Insul Resist. 2019;4(1): a49. https://doi.org/10.4102/jir.v4i1.49

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. https://pubmed.ncbi.nlm.nih.gov/11368702 https://doi.org/10.1001/jama.285.19.2486

Calderón-Gerstein WS, López-Peña A, Macha-Ramírez R,et al. Endothelial dysfunction assessment by flow-mediated dilation in a high-altitude population. Vasc Health Risk Manag. 2017;13:421-6. https://pubmed.ncbi.nlm.nih.gov/29200863 https://doi.org/10.2147/VHRM.S151886

Kuvin JT, Patel AR, Sliney KA, et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol. 2001;38(7):1843-9. https://pubmed.ncbi.nlm.nih.gov/11738283 https://doi.org/10.1016/s0735-1097(01)01657-6

Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23(3):295-301. https://pubmed.ncbi.nlm.nih.gov/10868854 https://doi.org/10.2337/diacare.23.3.295

Sciacqua A, Maio R, Miceli S, et al. Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS One. 2012;7(9):e44470. https://pubmed.ncbi.nlm.nih.gov/23028545 https://doi.org/10.1371/journal.pone.0044470

Wagenknecht LE, Mayer EJ, Rewers M, et al. The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 1995;5(6):464-72. https://pubmed.ncbi.nlm.nih.gov/8680609 https://doi.org/10.1016/1047-2797(95)00062-3

Fonseca VA. Early identification and treatment of insulin resistance: impact on subsequent prediabetes and type 2 diabetes. Clin Cornerstone. 2007;8 Suppl 7:S7-18. https://pubmed.ncbi.nlm.nih.gov/18159645 https://doi.org/10.1016/s1098-3597(07)80017-2

Thomas DD, Corkey BE, Istfan N, Apovian CM. Hyperinsulinemia: an early indicator of metabolic dysfunction. J Endocr Soc. 2019;3(9):1727-47. https://pubmed.ncbi.nlm.nih.gov/31528832 https://doi.org/10.1210/js.2019-00065

Cabrera de León A, Oliva García JG, Marcelino Rodríguez I, et al. C-peptide as a risk factor of coronary artery disease in the general population. Diab Vasc Dis. Res 2015;12(3):199-207. https://pubmed.ncbi.nlm.nih.gov/25696117 https://doi.org/10.1177/1479164114564900

Layton J, Li X, Shen C, et al. Type 2 diabetes genetic risk scores are associated with increased type 2 diabetes risk among African Americans by cardiometabolic status. Clin Med Insights Endocrinol Diabetes. 2018;11:1179551417748942. https://pubmed.ncbi.nlm.nih.gov/29326538 https://doi.org/10.1177/1179551417748942l

Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42(7):1149-60. https://pubmed.ncbi.nlm.nih.gov/14522472 https://doi.org/10.1016/s0735-1097(03)00994-x

Quyyomi AA. Prognostic value of endothelial function. Am J Cardiol. 2003;91(12A):19-24H. https://pubmed.ncbi.nlm.nih.gov/12818731 https://doi.org/10.1016/s0002-9149(03)00430-2